DarioHealth Expands Platform with New Sleep and Women’s Health Solutions
Key takeaways:Dario Sleep enables eligible members to complete a clinical-grade home sleep test with data sent directly to licensed healthcare providers. Treatment pathways for obstructive sleep apnea may. . .
Key takeaways:Dario Sleep enables eligible members to complete a clinical-grade home sleep test with data sent directly to licensed healthcare providers. Treatment pathways for obstructive sleep apnea may include positional therapy, oral appliance therapy, CPAP, or GLP-1 treatment. Both programs are expected to roll out to Fortune 500 and other enterprise clients in the fall of 2026. Healthcare technology company DarioHealth Corp recently released Dario Women and Dario Sleep, two new programs expanding its provider-backed cardiometabolic platform. The programs address drivers of cardiometabolic health through an integrated care experience that combines artificial intelligence (AI)-powered engagement, behavioral support, and access to licensed healthcare providers. The offerings come as demand from large enterprise payers for multi-condition solutions continues to rise. Dario Sleep addresses obstructive sleep apnea (OSA), a contributor to cardiometabolic disease and rising healthcare costs. The program enables eligible members to complete a one-night, clinical-grade home sleep test with real-time data transmitted directly to licensed healthcare providers for evaluation. Based on individual clinical needs, providers determine appropriate treatment pathways, which may include positional therapy, oral appliance therapy, CPAP therapy, or GLP-1 treatment when clinically appropriate. Dario Women supports membersnavigating perimenopause and menopause, life stages frequently associated with sleep disruption, weight changes, metabolic changes, and increased cardiometabolic risk. Eligible members may receive clinical evaluation for hormone replacement therapy when medically appropriate, following a clinical assessment conducted in accordance with evidence-based guidelines. “Women’s health and sleep represent significant opportunities to improve cardiometabolic outcomes while expanding the value we deliver to employers, health plans and members,” says Erez Raphael, CEO at Dario, in a release. “As we continue adding clinical capabilities to our platform, we strengthen our ability to support members throughout their healthcare journey while creating new opportunities to grow revenue through healthcare services that extend beyond digital engagement. ”Members enrolled in Dario Women and Dario Sleep continue their care journey through Dario’s integrated healthcare platform, which combines connected devices, AI-powered insights, personalized coaching, and provider-backed clinical care. “Our goal is to connect members with the right care through one coordinated experience,” says Lara Dodo, chief operating officer at Dario, in a release. More in Cardiometabolic Health:ID46373449©Tmcphotos|Dreamstime. com